Filtros de búsqueda

Lista de obras de Gion M

3rd EORTC-NCI International Meeting on Cancer Molecular Markers: From Discovery to Clinical Practice.

artículo científico publicado en 2004

A guide for reviewing submitted manuscripts (and indications for the design of translational research studies on biomarkers)

scientific article published on 01 July 1999

A mucinous-like carcinoma-associated antigen (MCA) in the tissue and blood of patients with primary breast cancer

artículo científico publicado en 1989

A new approach to tumour marker assessment by perioperative determination in breast and colorectal cancer

scientific article published on 01 January 1993

Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer.

artículo científico publicado en 2009

Aldosterone Regulation in Primary Aldosteronism: Differences between Adenoma and Bilateral Hyperplasia ⬇️

artículo científico publicado el 1 de diciembre de 1976

Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access OV Monitor assay on the UniCel Dxl 800 Immunoassay System

scientific article published on 01 January 2008

Alternative antibody for the detection of CA15-3 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access BR Monitor assay on the UniCel Dxl 800 Immunoassay System

scientific article published on 01 January 2008

Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access GI Monitor assay on the UniCel Dxl 800 Immunoassay System

scientific article published on 01 January 2008

An Italian program of External Quality Control for chromogranin A (CgA) assay: performance evaluation of CgA determination

article

An epidemiology-based model as a tool to monitor the outbreak of inappropriateness in tumor marker requests: a national scale study

artículo científico publicado en 2015

An epidemiology-based model to estimate the rate of inappropriateness of tumor marker requests

artículo científico publicado en 2014

Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers.

artículo científico publicado en 2012

Appropriateness of the use of clinical and radiologic examinations and laboratory tests in the follow-up of surgically-treated breast cancer patients. Results of the Working Group on the Clinical Aspects of Follow-up

artículo científico publicado en 1995

Appropriateness of tumor marker request: a case of study

artículo científico publicado en 2017

Are E-test and Vitek2 good choices for tigecycline susceptibility testing when comparing broth microdilution for MDR and XDR Acinetobacter baumannii?

artículo científico publicado en 2014

Biochemical parameters for prognostic evaluation in patients with breast cancer

scientific article published on 01 March 1994

Biochemical parameters in the cytosol of breast cancer

scientific article published on 01 January 1988

Biological variability evaluation and comparison of three different methods for C-peptide measurement

scientific article published on 01 January 2008

Biological variation of plasma chromogranin A.

artículo científico publicado en 2004

Biological variation of total prostate-specific antigen: a survey of published estimates and consequences for clinical practice.

artículo científico publicado en 2005

Biological variation of vascular endothelial growth factor

scientific article published on 01 January 2005

Biomolecular features of clinical relevance in breast cancer.

artículo científico publicado en 2004

CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 cases

artículo científico publicado en 2001

CEA, TPA and CA 15.3 in tissue and serum of breast cancer patients

artículo científico publicado en 1992

Ca549 immunoassay in breast-tissue - comparison with ca15.3 and mca

artículo científico publicado en 1993

Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis

artículo científico publicado en 2013

Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinoma

artículo científico publicado en 1986

Carcinoembryonic antigen, ferritin, tissue polypeptide antigen, and CA15/3 in breast cancer: relationship between carcinoma and normal breast tissue.

artículo científico publicado en 1986

Cathepsin D versus other prognostic factors in breast cancer. Results and controversies of a multicenter study on 2575 cases

artículo científico publicado en 1996

Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study

article

Circulating Sex Hormones and Tumor Characteristics in Postmenopausal Breast Cancer Patients. A Cross-Sectional Study

artículo científico publicado en 2011

Circulating biomarkers from tumour bulk to tumour machinery: promises and pitfalls.

artículo científico publicado en 2004

Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 1)

artículo científico publicado en 2016

Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 2).

artículo científico publicado en 2017

Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 3).

artículo científico publicado en 2017

Clinical evaluation of percent free prostate-specific antigen using the AxSYM system in the best analytical scenario

artículo científico publicado en 2000

Clinical evaluation of the iXip index to reduce prostate re-biopsies

scientific article published on 19 July 2018

Clinical profile of a new monoclonal antibody-based immunoassay for tissue polypeptide antigen

scientific article published on 01 October 1994

Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implications

artículo científico publicado en 1997

Comparison between single saturating dose ligand binding assay and enzyme immunoassay for low-salt extractable oestrogen and progesterone receptors in breast cancer: a multicentre study

artículo científico publicado en 1991

Comparison between western blotting, immunohistochemical and ELISA assay for p185neu quantitation in breast cancer specimens

artículo científico publicado en 1993

Comparison of immunoassays for tumor markers CA 19-9, CA 15-3 and CA 125: data from an international quality assessment scheme.

artículo científico publicado en 1995

Comparison of the diagnostic accuracy of CA27.29 and CA15.3 in primary breast cancer

scientific article published on 01 May 1999

Considerations on development, validation, application, and quality control of immuno(metric) biomarker assays in clinical cancer research: an EORTC-NCI working group report

artículo científico publicado el 1 de diciembre de 2003

Correction to: Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients

artículo científico publicado en 2018

Cost/effectiveness ratio of carcinoembryonic antigen--importance of adequacy of routine requests of tumor markers

artículo científico publicado el 1 de julio de 1992

Detection of different estrogen receptor forms in breast cancer cytosol by enzyme immunoassay

artículo científico publicado en 1997

Determination of ErbB2 protein in breast cancer tissues by different methods. Relationships with other biological parameters

artículo científico publicado en 1996

Determination of cytoplasmic estrogen and progesterone receptors in breast carcinoma: comparison of a histochemical and a radiometric method

scientific article published on 01 May 1985

Development of a website and biobank database for the Nanosized Cancer Polymarker Biochip Project: a Multicenter Italian Experience.

artículo científico

Differential liquid phase proteomic analysis of the effect of selenium supplementation in LNCaP cells.

artículo científico publicado en 2008

ELISA assay employing epitope-specific monoclonal antibodies to quantify circulating HER2 with potential application in monitoring cancer patients undergoing therapy with trastuzumab

scientific article published on 20 February 2020

Editor's comments: the role of inflammation in the development and progression of cancer

article

Epidemiology-based assessment of tumor marker overordering in breast cancer: an algorithm to examine different disease conditions

artículo científico publicado en 2017

Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue.

artículo científico publicado en 1993

Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue ⬇️

artículo científico publicado el 1 de octubre de 1991

Epidermal growth-factor receptor and erbb2 protein in colorectal tissue - comparison between cancer and normal mucosa ⬇️

artículo científico publicado el 1 de octubre de 1992

Epidermal growth-factor receptors and erbb2 protein expression in esophageal cancer and normal mucosa.

artículo científico publicado en 1995

ErbB2 assay in breast cancer: possibly improved clinical information using a quantitative method

scientific article published on 01 March 1997

Evaluating Serum Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor Binding Protein 3 as Markers in Prostate Cancer Diagnosis

artículo científico publicado en 2016

Evaluation of CA15/3 serum levels in breast cancer patients

artículo científico publicado en 1986

Evaluation of HER-2/neu in serum and tissue of primary and metastatic breast cancer patients using an automated enzyme immunoassay

artículo científico publicado en 2001

Evaluation of a new IRMA method for the determination of neuron specific enolase

artículo científico publicado en 1990

Evaluation of a radioreceptor assay to assess exogenous estrogen activity in serum of patients with breast cancer.

artículo científico publicado en 1991

Evaluation of a sex hormone-binding globulin automated chemiluminescent assay.

artículo científico publicado en 2013

Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis

artículo científico publicado en 2009

Evaluation of critical differences of CEA and CA 15.3 levels in serial samples from patients operated for breast cancer

artículo científico publicado en 1994

Evaluation of the HB&L System for the Microbiological Screening of Storage Medium for Organ-Cultured Corneas.

artículo científico publicado en 2013

Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis

artículo científico publicado en 2010

Flexible modelling in survival analysis. Structuring biological complexity from the information provided by tumor markers

artículo científico publicado en 1998

Gefitinib (ZD1839) combined with weekly epirubicin in patients with metastatic breast cancer: a phase I study with biological correlate.

artículo científico publicado en 2005

HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study

artículo científico publicado en 2016

How CA 125 is used in the routine follow-up of ovarian cancer: a survey of 29 Italian hospitals.

artículo científico publicado en 1998

How tumor markers are used in the routine follow-up of breast and colorectal cancer. A survey of 29 Italian hospitals

scientific article published on 01 July 1998

Human Chorionic Gonadotropin Assays for Testicular Tumors: Closing the Gap between Clinical and Laboratory Practice.

artículo científico publicado en 2017

Immunoenzymatic assay of erbB2 protein in cancer and non-malignant breast tissue. Relationships with clinical and biochemical parameters

artículo científico publicado en 1992

Immunoprecipitation method for a radioligand binding assay of epidermal growth factor receptor

scientific article published on 01 October 1990

Impact of Steroid Receptors, pS2 and Cathepsin D on the Outcome of N+ Postmenopausal Breast Cancer Patients Treated with Tamoxifen ⬇️

artículo científico publicado el 1 de enero de 1998

Indicators of inappropriate tumour marker use through the mining of electronic health records

artículo científico publicado en 2017

Inflammation Markers: New Actors in the Cancer Biomarker Tale

artículo científico publicado en 2013

Insufficient uptake of systematic search methods in oncological clinical practice guideline: a systematic review

artículo científico publicado en 2019

Interchangeability between control material and patient serum in tumor biomarker assessment

artículo científico publicado en 2003

Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives.

artículo científico publicado en 2010

Is tissue polypeptide antigen still a useful tumor marker in breast carcinoma? Comparison with CA15.3 and MCA

artículo científico publicado en 1990

Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms.

artículo científico publicado en 2014

Kinetic use of tumor markers in the follow-up of patients operated for primary breast cancer

scientific article published on 01 October 1990

More about: prognostic importance of low c-erbB2 expression in breast tumors

artículo científico publicado en 2000

Need for knowledge translation to improve tumor marker application.

artículo científico publicado en 2016

New Frontiers in Tumor Marker Studies: From Biobanking to Collaboration in Translational Research

artículo científico publicado en 2011

Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients.

artículo científico publicado en 2018

Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditions

artículo científico publicado en 1998

Perioperatory kinetic evaluation of tumor markers in breast and colorectal carcinoma

artículo científico publicado en 1990

Phase II study of liposome-encapsulated doxorubicin plus cyclophosphamide, followed by sequential trastuzumab plus docetaxel as primary systemic therapy for breast cancer patients with HER2 overexpression or amplification.

artículo científico publicado en 2013

Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study).

artículo científico publicado en 2011

Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial

scientific article published on 31 March 2018

Preanalytical stability of [-2]proPSA in whole blood stored at room temperature before separation of serum and plasma: implications to Phi determination

scientific article published on 01 March 2019

Preliminary evaluation of CYFRA 21-1 in lung cancer cytosol

scientific article published on 01 October 1994

Preliminary results of clinical evaluation of the free/total prostate-specific antigen ratio in a multicentric study

scientific article published on 01 November 1996

Primary hyperaldosteronism syndrome

artículo científico publicado el 8 de junio de 1979

Prognostic and predictive molecular markers: Are we ready for their clinical use? The opinion of a clinical biochemist ⬇️

artículo científico publicado el 1 de enero de 2003

Prognostic role of serum CA15.3 in 362 node-negative breast cancers. An old player for a new game

artículo científico publicado en 2002

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma

scientific article published on 01 January 1997

Prognostic value of circulating KRAS2 gene mutations in colorectal cancer with distant metastases

artículo científico publicado en 2006

Prostate cancer probability after total PSA and percent free PSA determination

artículo científico publicado en 1998

Prostate-specific antigen as a unique routine test in monitoring therapy for inoperable prostate cancer: comparison with radionuclide bone scan and prostatic acid phosphatase

scientific article published on 01 January 1995

Quantitative chemiluminescent immunoassay of p53: prognostic significance in 220 node-negative breast cancer tissue

artículo científico publicado en 1997

Quantitative measurement of soluble cytokeratin fragments in tissue cytosol of 599 node negative breast cancer patients: a prognostic marker possibly associated with apoptosis

artículo científico publicado en 2000

Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives

scientific article published on 25 May 2019

Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer

scientific article published on 01 January 1995

Relationship between cytosol TPS, TPA and cell proliferation

artículo científico publicado en 1994

Relationship between prostatic acid phosphatase and prostate-specific antigen serum levels and prostatic volume in benign prostate hyperplasia. Pitfall on tumor markers assessment in primary prostatic cancer?

scientific article published on 01 January 1992

Reporting recommendations for tumor marker prognostic studies

scientific article published on 19 September 2005

Reporting recommendations for tumor marker prognostic studies (remark).

artículo científico publicado en 2006

Research trends for early cancer biomarker detection in Italy: an integrated program in oncology (PIO) survey.

artículo científico publicado en 2010

Serial determination of CEA and CA 15.3 in breast cancer follow-up: an assessment of their diagnostic accuracy for the detection of tumour recurrences.

artículo científico publicado en 2009

Serum tumour markers: from quality control to total quality management

artículo científico publicado en 2000

Shed HER2 surrogacy evaluation in primary breast cancer patients: a study assessing tumor tissue HER2 expression at both extracellular and intracellular levels

scientific article published on 15 April 2019

Simultaneous determination of gemcitabine di- and triphosphate in human blood mononuclear and cancer cells by RP-HPLC and UV detection.

artículo científico publicado en 2006

Sirtuin 1 stabilization by HuR represses TNF-α- and glucose-induced E-selectin release and endothelial cell adhesiveness in vitro: relevance to human metabolic syndrome.

artículo científico publicado en 2014

Standardization of assay for cytokeratin-related tumor marker CYFRA21.1 in urine samples

scientific article published on 01 October 1996

Study on in-vitro susceptibility of ESBL-positive Escherichia coli isolated from urine specimens

artículo científico publicado en 2010

TAF test in primary esophageal carcinoma: comparison with other tumor markers

artículo científico publicado en 1991

Testosterone and biological characteristics of breast cancers in postmenopausal women.

artículo científico publicado en 2009

The combination of the selective cyclooxygenase-2 inhibitor celecoxib with weekly paclitaxel is a safe and active second-line therapy for non-small cell lung cancer: a phase II study with biological correlates.

artículo científico publicado en 2005

The correlation between serum levels of cytokeratin tumor markers does reflect their molecular characterization

artículo científico publicado en 1994

The prognostic significance of increasing marker levels in metastatic breast cancer patients with clinically complete remission, partial remission or stable disease.

artículo científico publicado en 1998

The prognostic value of vascular endothelial growth factor, urokinase plasminogen activator and plasminogen activator inhibitor-1 in node-negative breast cancer

scientific article published on 01 October 2004

The role of HE4 in ovarian cancer follow-up: a review.

artículo científico publicado en 2014

Third-generation PSA: ultrasensitive or ultraprecise assay?

scientific article published on 01 October 1995

Tissue polypeptide antigen and tissue polypeptide specific antigen in primary breast cancer. Evaluation in serum and tumour tissue

artículo científico publicado en 1994

Tissue polypeptide antigen as a putative indicator of apoptosis

artículo científico publicado en 1998

Tissue polypeptide antigen in breast cancer cytosol: a new effective prognostic indicator

artículo científico publicado en 1992

Tissue polypeptide antigen in tumor cytosol: a new prognostic indicator in primary breast cancer

artículo científico publicado en 1990

Tumor marker radioimmunoassays in gastric juice. Methodologic drawbacks due to pH variations

artículo científico publicado en 1988

Tumor markers in breast cancer follow-up: a potentially useful parameter still awaiting definitive assessment. Forza Operativa Nazionale sul Carcinoma Mammario (FONCaM).

artículo científico publicado en 1995

Tumor markers in breast cancer monitoring should be scheduled according to initial stage and follow-up time: a prospective study on 859 patients

artículo científico publicado en 2001

Tumor markers in breast cancer- European Group on Tumor Markers recommendations.

artículo científico publicado en 2005

Tumor markers in serum of patients with primary squamous cell carcinoma of the esophagus

artículo científico publicado en 1989

Tumor markers in squamous cell carcinoma of esophagus: immunometric assay in cytosol and membrane fraction.

artículo científico publicado en 1990

Tumor-associated trypsin inhibitor (TATI) in primary esophageal carcinoma

artículo científico publicado en 1991

Tumour markers requesting pattern with regards to different organizational settings in Italy: a survey of hospital laboratories

scientific article published on 01 June 2009

Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments.

artículo científico publicado en 2001

Variability of tumor markers in the follow-up of patients radically resected for breast cancer

artículo científico publicado en 1993

Within-subject biological variation in disease: the case of tumour markers

artículo científico publicado en 2008

[Effect of diazoxide on blood pressure, PRA and plasma aldosterone in hypertensive patients (author's transl)]

artículo científico publicado en 1976

[Expression of estrogen receptors in breast cancer detected by various methods: lack of correlation]

scientific article published on 01 August 1997

[Response to a cognitive questionnaire on the guideline project of prostatic biopsy of the SIEUN--GUONE--SIUrO--SIBioC]

artículo científico publicado en 2002

[Study on in vitro susceptibility of Candida spp. isolated from blood culture]

artículo científico publicado en 2012

c-erbB-2/neu protein expression, DNA ploidy and S phase in breast cancer

artículo científico publicado en 1996

editor's comments

article

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda